查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
活用AI的藥物研發·臨床試驗的全球市場(2023年～2033年)
市場調查報告書
商品編碼
1302963

活用AI的藥物研發·臨床試驗的全球市場(2023年～2033年)

AI-Enabled Drug Discovery and Clinical Trials Market Report 2023-2033
出版日期: | 出版商: Visiongain Reports Ltd. | 英文 267 Pages | 商品交期: 最快1-2個工作天內

價格

全球AI的藥物研發·臨床試驗的市場規模在2033年前將以26.5％的年複合成長率成長。醫療上AI用途的認知度提高，促進了市場的成長。可是，但熟練的人力資源不足，阻礙了市場成長。

本報告提供全球AI的藥物研發·臨床試驗市場的相關調查，提供市場概要，市場分析，企業簡介等全面性資訊。

目錄

第1章 報告概要

第2章 摘要整理

第3章 市場概要

  • 主要調查結果
  • 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
  • COVID-19影響分析
  • 波特的五力分析
    • 供給企業談判力
    • 買方議價能力
    • 競爭企業間的敵對關係
    • 替代品的威脅
    • 新加入廠商業者的威脅
  • PEST分析

第4章 活用AI的藥物研發·臨床試驗市場分析:各零件

  • 主要調查結果
  • 零組件市場區隔:市場魅力指數
  • 活用AI的藥物研發·臨床試驗的市場規模的估計與預測:各零件
  • 服務
  • 軟體解決方案

第5章 活用AI的藥物研發·臨床試驗市場分析:各用途

  • 主要調查結果
  • 用途市場區隔:市場魅力指數
  • 活用AI的藥物研發·臨床試驗的市場規模的估計與預測:各用途
  • 臨床試驗
  • 藥物設計
  • 資料的集中與分析
  • 藥物特徵評估
  • 生物標記研究
  • 其他

第6章 活用AI的藥物研發·臨床試驗市場分析:各治療領域

  • 主要調查結果
  • 治療領域市場區隔:市場魅力指數
  • 活用AI的藥物研發·臨床試驗的市場規模的估計與預測:各治療領域
  • 腫瘤
  • 心血管疾病
  • 感染疾病
  • 神經退化性疾病
  • 代謝性疾病
  • 其他

第7章 活用AI的藥物研發·臨床試驗市場分析:各終端用戶

  • 主要調查結果
  • 終端用戶市場區隔:市場魅力指數
  • 活用AI的藥物研發·臨床試驗的市場規模的估計與預測:各終端用戶
  • 製藥企業及生物醫藥品企業
  • 受託研究機構(CRO)
  • 其他

第8章 活用AI的藥物研發·臨床試驗市場分析:各地區

  • 主要調查結果
  • 地區的市場規模的估計與預測

第9章 北美的AI的藥物研發·臨床試驗市場分析

第10章 歐洲的AI的藥物研發·臨床試驗市場分析

第11章 亞洲的AI的藥物研發·臨床試驗市場分析

第12章 南美的AI的藥物研發·臨床試驗市場分析

第13章 中東·非洲的AI的藥物研發·臨床試驗市場分析

第14章 企業簡介

  • 競爭情形(2022年)
  • 策略的展望
  • IBM Watson
  • Saama Technologies
  • PathAI
  • GNS Healthcare
  • Unlearn.AI, Inc.
  • Novartis AG
  • Merck &Co., Inc.
  • AbbVie Inc.
  • Exscientia

第15章 結論與推薦事項

  • 結論
  • 對市場參與者的建議
Product Code: PHA1267

The global AI-Enabled Drug Discovery and Clinical Trials market is projected to grow at a CAGR of 26.5% by 2033.

“The AI-Enabled Drug Discovery and Clinical Trials Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Awareness of AI applications in Healthcare is Boosting the Market Growth

With the rise of AI applications in healthcare services, people's awareness and acceptance of AI-enabled solutions have grown. More pharmaceutical companies are, therefore, seeking to incorporate these solutions into their drug discovery and clinical trial processes. AI-based drug delivery solutions are becoming increasingly popular in the pharmaceutical industry. These solutions involve using artificial intelligence technologies to develop more efficient and effective drug delivery methods. The use of AI in drug delivery has the potential to transform the industry by reducing costs, improving drug efficacy and safety, and providing better patient outcomes.

The market for AI-based drug delivery solutions is expected to grow in the coming years, with a number of companies already offering or developing such solutions. Some of the key players in this market include:

  • Novartis - Novartis is one of the leading players in the AI-based drug delivery market, with a focus on developing smart inhalers to treat respiratory diseases
  • Medtronic - Medtronic is a medical devices company that is building an AI-based drug delivery platform to improve the delivery of insulin for diabetic patients
  • Insilico Medicine - Insilico Medicine is a drug discovery company that is using AI to develop new drugs and drug delivery methods
  • Johnson & Johnson - Johnson & Johnson is using AI to develop personalized drug delivery solutions, including smart drug-infused contact lenses and implantable drug delivery devices
  • GSK - GSK is using AI to develop inhalers that can adjust the dosage based on the patient's breathing pattern.

As the competition between market players intensifies, companies are investing heavily in research and development to stay ahead of the curve. This is driving innovation and pushing the boundaries of what is possible in the drug delivery industry. In the future, AI-based drug delivery solutions are likely to become increasingly sophisticated, personalized, and targeted, improving patient outcomes and transforming the pharmaceutical industry.

Lack of Skilled Personnel to Hinder the Market Growth

Patient safety is a significant challenge during the drug discovery phase, as activities involving the interpretation of drug effects and anticipation of potential side effects can pose a major constraint on the market. Additionally, the lack of skilled personnel and inadequate datasets for drug discovery and development are crucial factors that may impact market growth. The implementation of AI systems in drug discovery requires companies to possess expertise in system design, management, and implementation. Given the complexity of AI, personnel working with these systems need to have a deep understanding of technologies such as machine learning, deep learning, and other aspects of artificial intelligence. Integrating AI technologies into existing systems to replicate human brain behaviour necessitates substantial data processing. AI/ML development is being restricted owing to lack of professional standards and certifications.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the AI-enabled drug discovery and clinical trials market evolving?
  • What is driving and restraining the AI-enabled drug discovery and clinical trials market?
  • How will each AI-enabled drug discovery and clinical trials submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each AI-enabled drug discovery and clinical trials submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading AI-enabled drug discovery and clinical trials markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the AI-enabled drug discovery and clinical trials projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of AI-enabled drug discovery and clinical trials projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the AI-enabled drug discovery and clinical trials market?
  • Where is the AI-enabled drug discovery and clinical trials market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the AI-enabled drug discovery and clinical trials market today, and over the next 10 years:

  • Our 267-page report provides 102 tables and 151 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the AI-enabled drug discovery and clinical trials market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising AI-enabled drug discovery and clinical trials prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Component Outlook

  • Services
  • Software

Application

  • Clinical Trials
  • Drug Design
  • Data Aggregation and Analysis
  • Drug Characterization
  • Biomarker Research
  • Others

Therapeutic Area

  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurodegenerative Diseases
  • Metabolic Diseases
  • Others

End-user

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • AbbVie Inc
  • Exscientia
  • GNS Healthcare
  • IBM Watson
  • Merck & Co., Inc.
  • Novartis AG
  • PathAI
  • Saama Technologies
  • Unlearn.AI, Inc.

Overall world revenue for AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 in terms of value the market will surpass US$2,156.8 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 report help you?

In summary, our 260+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 Market, with forecasts for component, application, therapeutic area, and end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 18 key national markets - See forecasts for the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 9 of the major companies involved in the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the AI-Enabled Drug Discovery and Clinical Trials Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to AI-Enabled Drug Discovery and Clinical Trials Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Growing Demand for Personalized Medicine
      • 3.2.1.2 Advancements in Technology
      • 3.2.1.3 Growing Awareness of AI in Healthcare
      • 3.2.1.4 Cost-effectiveness of AI-enabled Solutions
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Lack of Skilled Personnel to Hamper the Market Growth
      • 3.2.2.2 Limited Data Availability is a Major Challenge in Adoption of AI-enabled Solutions
      • 3.2.2.3 Challenges Associated with Integration of New AI-enabled Solution with Existing Infrastructure
      • 3.2.2.4 Ethics and Data Privacy Issues Hindering the Market Growth
      • 3.2.2.5 Regulatory Hurdles Restraining the Global Market Growth
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Improved Patient Outcomes
      • 3.2.3.2 Increased Adoption Of AI-Enabled Solution By Pharma & Biopharma Companies For Clinical Trials
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Components

  • 4.1 Key Findings
  • 4.2 Components Segment: Market Attractiveness Index
  • 4.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
  • 4.4 Services
    • 4.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Software Solutions
    • 4.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Application

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 5.4 Clinical Trials
    • 5.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Drug Design
    • 5.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Data Aggregation and Analysis
    • 5.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)
  • 5.7 Drug Characterization
    • 5.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.7.2 Market Share by Region, 2023 & 2033 (%)
  • 5.8 Biomarker Research
    • 5.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.8.2 Market Share by Region, 2023 & 2033 (%)
  • 5.9 Others
    • 5.9.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.9.2 Market Share by Region, 2023 & 2033 (%)

6 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Therapeutic Area

  • 6.1 Key Findings
  • 6.2 Therapeutic Area Segment: Market Attractiveness Index
  • 6.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 6.4 Oncology
    • 6.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Cardiovascular Diseases
    • 6.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Infectious Diseases
    • 6.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Neurodegenerative Diseases
    • 6.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)
  • 6.8 Metabolic Diseases
    • 6.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.8.2 Market Share by Region, 2023 & 2033 (%)
  • 6.9 Others
    • 6.9.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.9.2 Market Share by Region, 2023 & 2033 (%)

7 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by End-User

  • 7.1 Key Findings
  • 7.2 End-User Segment: Market Attractiveness Index
  • 7.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-User
  • 7.4 Pharmaceutical & Biopharmaceutical Companies
    • 7.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Contract Research Organizations (CROs)
    • 7.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
  • 7.6 Others
    • 7.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.6.2 Market Share by Region, 2023 & 2033 (%)

8 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 9.1 Key Findings
  • 9.2 North America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 9.3 North America AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 9.4 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 9.5 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
  • 9.6 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 9.7 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 9.8 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
  • 9.9 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 9.10 Canada AI-Enabled Drug Discovery and Clinical Trials Market Analysis

10 Europe AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 10.3 Europe AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 10.4 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 10.5 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
  • 10.6 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 10.7 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 10.8 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
  • 10.9 Germany AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.10 UK AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.11 France AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.12 Italy AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.13 Spain AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.14 Russia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.15 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Analysis

11 Asia AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 11.3 Asia AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 11.4 Asia AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
  • 11.6 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 11.7 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 11.8 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
  • 11.9 Japan AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.10 China AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.11 India AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.12 Australia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.13 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.14 Rest of Asia AI-Enabled Drug Discovery and Clinical Trials Market Analysis

12 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 12.3 Latin America AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 12.4 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 12.5 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
  • 12.6 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 12.7 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 12.8 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
  • 12.9 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 12.10 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 12.11 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 12.12 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Analysis

13 MEA AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 13.3 MEA AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 13.4 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 13.5 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Components
  • 13.6 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 13.7 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 13.8 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-user
  • 13.9 GCC AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 13.10 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 13.11 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Analysis

14 Company Profiles

  • 14.1 Company Share Analysis, 2022
  • 14.2 Strategic Outlook
  • 14.3 IBM Watson
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2019 -2022
      • 14.3.3.2 R&D, 2019-2022
      • 14.3.3.3 Regional Market Shares, 2022
    • 14.3.4 Service Benchmarking
    • 14.3.5 Strategic Outlook
  • 14.4 Saama Technologies
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Service Benchmarking
    • 14.4.4 Strategic Outlook
  • 14.5 PathAI
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Service Benchmarking
    • 14.5.4 Strategic Outlook
  • 14.6 GNS Healthcare
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Service Benchmarking
    • 14.6.4 Strategic Outlook
  • 14.7 Unlearn.AI, Inc.
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Service Benchmarking
    • 14.7.4 Strategic Outlook
  • 14.8 Novartis AG
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
      • 14.8.3.1 Net Revenue, 2020 -2022
    • 14.8.4 Service Benchmarking
    • 14.8.5 Strategic Outlook
  • 14.9 Merck & Co., Inc.
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
      • 14.9.3.1 Net Revenue, 2019-2021
    • 14.9.4 Service Benchmarking
    • 14.9.5 Strategic Outlook
  • 14.10 AbbVie Inc.
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis
      • 14.10.3.1 Net Revenue, 2019-2021
    • 14.10.4 Service Benchmarking
    • 14.10.5 Strategic Outlook
  • 14.11 Exscientia
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Service Benchmarking
    • 14.11.4 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from
  • 15.2 Recommendations for Market Players

List of Tables

  • Table 1 AI-Enabled Drug Discovery and Clinical Trials Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
  • Table 2 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 7 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 8 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 9 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 10 Clinical Trials Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 11 Drug Design Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 12 Data Aggregation and Analysis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 13 Drug Characterization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 14 Biomarker Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 15 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 16 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 17 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 18 Cardiovascular Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 19 Infectious Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 20 Neurodegenerative Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 21 Metabolic Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 22 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 23 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 24 Pharmaceutical & Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 25 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 26 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 27 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 28 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 29 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 30 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 31 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 32 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 33 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 34 Canada AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 35 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 36 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 37 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 38 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 39 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 40 Germany AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 41 UK AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 42 France AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 43 Italy AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 44 Spain AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 45 Russia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 46 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 47 Asia AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 48 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 49 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 50 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 51 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 52 Japan AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 53 China AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 54 India AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 55 Australia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 56 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 57 Rest of Asia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 58 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 59 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 60 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 61 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 62 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 63 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 64 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 65 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 66 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 67 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 68 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 69 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 70 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 71 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 72 GCC AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 73 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 74 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 75 Strategic Outlook
  • Table 76 IBM Watson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 77 IBM: Service Benchmarking
  • Table 78 IBM: Strategic Outlook
  • Table 79 Saama Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 80 Saama Technologies: Service Benchmarking
  • Table 81 Saama Technologies: Strategic Outlook
  • Table 82 PathAI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 83 PathAI: Service Benchmarking
  • Table 84 PathAI: Strategic Outlook
  • Table 85 GNS Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 86 GNS Healthcare: Service Benchmarking
  • Table 87 GNS Healthcare: Strategic Outlook
  • Table 88 Unlearn.AI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 Unlearn.AI: Service Benchmarking
  • Table 90 Unlearn.AI: Strategic Outlook
  • Table 91 Novartis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 92 Novartis: Service Benchmarking
  • Table 93 Novartis: Strategic Outlook
  • Table 94 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 95 Merck & Co. Inc.: Service Benchmarking
  • Table 96 Novartis: Strategic Outlook
  • Table 97 Abbvie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 AbbVie Inc.: Service Benchmarking
  • Table 99 Exscientia: Strategic Outlook
  • Table 100 Exscientia: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 Exscientia: Service Benchmarking
  • Table 102 Exscientia: Strategic Outlook
  •  

List of Figures

  • Figure 1 AI-Enabled Drug Discovery and Clinical Trials Market Segmentation
  • Figure 2 AI-Enabled Drug Discovery and Clinical Trials Market by Component: Market Attractiveness Index
  • Figure 3 AI-Enabled Drug Discovery and Clinical Trials Market by Application: Market Attractiveness Index
  • Figure 4 AI-Enabled Drug Discovery and Clinical Trials Market by Therapeutic Area Market Attractiveness Index
  • Figure 5 AI-Enabled Drug Discovery and Clinical Trials Market by End-user: Market Attractiveness Index
  • Figure 6 AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index by Region
  • Figure 7 AI-Enabled Drug Discovery and Clinical Trials Market: Market Dynamics
  • Figure 8 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): "V" Shaped Recovery
  • Figure 9 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): "U" Shaped Recovery
  • Figure 10 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): "W" Shaped Recovery
  • Figure 11 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %): "L" Shaped Recovery
  • Figure 12 AI-Enabled Drug Discovery and Clinical Trials Market: Porter's Five Forces Analysis
  • Figure 13 AI-Enabled Drug Discovery and Clinical Trials Market: PEST Analysis
  • Figure 14 AI-Enabled Drug Discovery and Clinical Trials Market by Components: Market Attractiveness Index
  • Figure 15 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
  • Figure 16 AI-Enabled Drug Discovery and Clinical Trials Share Forecast by Components, 2023, 2028, 2033 (%)
  • Figure 17 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 18 Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 19 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 20 Software Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 21 AI-Enabled Drug Discovery and Clinical Trials Market by Application: Market Attractiveness Index
  • Figure 22 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 23 AI-Enabled Drug Discovery and Clinical Trials Share Forecast by Application, 2023, 2028, 2033 (%)
  • Figure 24 Clinical Trials Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 25 Clinical Trials Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 26 Drug Design Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 27 Drug Design Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 28 Data Aggregation and Analysis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 29 Data Aggregation and Analysis Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 30 Drug Characterization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 31 Drug Characterization Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 32 Biomarker Research Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 33 Biomarker Research Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 34 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 35 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 36 AI-Enabled Drug Discovery and Clinical Trials Market by Therapeutic Area: Market Attractiveness Index
  • Figure 37 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
  • Figure 38 AI-Enabled Drug Discovery and Clinical Trials Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
  • Figure 39 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 40 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 41 Cardiovascular Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 42 Cardiovascular Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 43 Infectious Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 44 Infectious Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 45 Neurodegenerative Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 46 Neurodegenerative Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 47 Metabolic Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 48 Metabolic Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 49 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 50 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 51 AI-Enabled Drug Discovery and Clinical Trials Market by End-User: Market Attractiveness Index
  • Figure 52 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-User, 2023-2033 (US$ Million, AGR %)
  • Figure 53 AI-Enabled Drug Discovery and Clinical Trials Share Forecast by End-User, 2023, 2028, 2033 (%)
  • Figure 54 Pharmaceutical & Biopharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 55 Pharmaceutical & Biopharmaceutical Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 56 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 57 Contract Research Organizations (CROs) Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 58 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 59 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 60 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
  • Figure 61 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Region 2023, 2028, 2033 (%)
  • Figure 62 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 63 North America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • Figure 64 North America AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 65 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 66 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 67 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
  • Figure 68 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
  • Figure 69 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 70 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 71 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
  • Figure 72 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 73 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
  • Figure 74 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
  • Figure 75 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 76 Canada AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 77 Europe AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • Figure 78 Europe AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 79 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 80 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 81 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
  • Figure 82 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
  • Figure 83 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 84 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 85 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
  • Figure 86 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 87 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
  • Figure 88 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
  • Figure 89 Germany AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 90 UK AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 91 France AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 92 Italy AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 93 Spain AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 94 Russia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 95 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 96 Asia AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • Figure 97 Asia AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 98 Asia AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 99 Asia AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 100 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
  • Figure 101 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
  • Figure 102 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 103 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 104 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
  • Figure 105 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 106 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
  • Figure 107 Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
  • Figure 108 Japan AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 109 China AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 110 India AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 111 Australia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 112 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 113 Rest of Asia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 114 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • Figure 115 Latin America AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 116 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 117 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 118 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
  • Figure 119 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
  • Figure 120 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 121 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 122 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
  • Figure 123 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 124 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
  • Figure 125 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
  • Figure 126 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 127 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 128 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 129 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 130 MEA AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • Figure 131 MEA AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 132 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 133 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 134 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Components, 2023-2033 (US$ Million, AGR %)
  • Figure 135 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Components, 2023 & 2033 (%)
  • Figure 136 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 137 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 138 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
  • Figure 139 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 140 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-user, 2023-2033 (US$ Million, AGR %)
  • Figure 141 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-user, 2023 & 2033 (%)
  • Figure 142 GCC AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 143 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 144 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 145 AI-Enabled Drug Discovery and Clinical Trials Market: Company Share Analysis, 2022
  • Figure 146 IBM: Net Revenue, 2019-2022 (US$ Million, AGR%)
  • Figure 147 IBM: R&D, 2019-2022 (US$ Million, AGR%)
  • Figure 148 IBM: Regional Market Shares, 2022
  • Figure 149 Novartis: Net Revenue, 2020-2022 (US$ Million, AGR%)
  • Figure 150 Merck: Net Revenue, 2019-2021 (US$ million, AGR %)
  • Figure 151 Net Revenue, 2019-2021 (US$ million, AGR %)